The global plasmid DNA manufacturing market reached USD 2.13 billion in 2024 and is projected to grow to approximately USD 10.56 billion by 2032, expanding at a CAGR of 22.15%. The GMP-grade segment dominated the market with an 87.43% share in 2024 and is expected to continue its growth trajectory, driven by the increasing demand for gene therapies, cell therapies, and DNA vaccines. T... https://advantiaglobal.com/reports/global-plasmid-dna-manufacturing-market-by-grade/